4th Macrophage-directed Therapies Summit, taking place from 4-6 of October in Boston, will bring together professionals to accelerate the clinical validation of macrophage-directed therapies, manipulating and fixing phenotypic plasticity to develop safe, targeted therapies for oncology, autoimmunity, inflammation and beyond.
- CD47 targeting and other ‘don’t eat me’ signals
- Safety concerns due to model translatability and dosing
- Optimal combination or monotherapy discovery
You can view the event guide here: https://ter.li/ezyi0h
Secure your place at the summit here: https://ter.li/x9p0ua
We are looking forward to welcoming you to Boston this October!